We are a charity and rely on donations
Charity Number: 1117194 (England and Wales)
Registered Company: 06000961
Registered address:
Shift.ms, Platform, New Station Street, LS1 4JB, United Kingdom
London office:
Shift.ms, Somerset House, Strand, West Goods Entrance, London WC2R 1LA, United Kingdom
©2025 Shift.ms
Hi I’m Angela n also am mobile n say that carefully because it’s not easy but as far as looking weight loss we are living with the same question sorry for not knowing 🥺
This for sure is something that needs to be discussed with your doctor but generally speaking and only taking into consideration the MS, according to the internet: GLP-1 receptor agonists (e.g., semaglutide [Ozempic®, Wegovy®], tirzepatide [Mounjaro®], dulaglutide [Trulicity®]) have been studied in MS patients and appear safe and well-tolerated.